Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients

医学 HBeAg 恩替卡韦 内科学 胃肠病学 复归 危险系数 乙型肝炎表面抗原 入射(几何) 累积发病率 替诺福韦 乙型肝炎病毒 免疫学 病毒 拉米夫定 人类免疫缺陷病毒(HIV) 置信区间 生物 队列 表型 物理 光学 基因 生物化学
作者
Yi–Cheng Chen,Chao‐Wei Hsu,Rong‐Nan Chien
出处
期刊:Journal of Medical Virology [Wiley]
卷期号:95 (11)
标识
DOI:10.1002/jmv.29213
摘要

Abstract A complete investigation of the clinical outcomes after treatment cessation in HBeAg‐positive patients with HBeAg loss is limited. We retrospectively recruited 242 HBeAg‐positive patients with HBeAg loss after a median duration of 37.2 months with tenofovir (TDF, n = 77) or entecavir (ETV, n = 165) treatment. There were 77 (31.8%) patients with sustained virological remission (SVR), 85 (35.1%) with HBeAg‐reversion virological relapse, 80 (33.1%) with HBeAg‐negative virological relapse after treatment cessation, and 23 (9.5%) with HBsAg loss. Clinical data at baseline, on‐treatment and during off‐treatment follow‐up were analyzed. The 3‐year cumulative incidences of overall, HBeAg‐reversion and HBeAg‐negative virological relapse were 70.2%, 54%, and 53.5%, respectively. The common factors associated with HBeAg‐reversion and HBeAg‐negative virological relapse were tenofovir treatment (hazard ratio [HR] = 5.411, p < 0.001; HR = 2.066, p = 0.006, respectively) and HBsAg at end of treatment (EOT) (HR = 1.461, p = 0.001; HR = 1.303, p = 0.019, respectively). The 5‐year cumulative incidence of HBsAg loss in SVR patients was 13.7% and EOT HBsAg was the only associated factor (HR = 0.524, p = 0.024). Compared to that of ETV‐treated patients, TDF‐treated patients had a significantly higher 3‐year cumulative incidence of virological relapse (87.3% vs. 62.8%, p < 0.001), earlier HBeAg‐reversion virological relapse (2.9 vs. 7.8 months, p < 0.001), a higher rate of HBeAg‐reversion virological relapse (53.2% vs. 26.7%) and a lower SVR rate (15.6% vs. 39.4%) ( p < 0.001). In summary, the clinical outcomes after treatment cessation in HBeAg‐positive patients with HBeAg loss were composed of HBeAg‐reversion virological relapse, HBeAg‐negative virological relapse and SVR. TDF was significantly associated with off‐treatment virological relapse. EOT HBsAg plays an important role in HBsAg loss among SVR patients and posttreatment virological relapse.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
JHM完成签到,获得积分10
1秒前
1秒前
共享精神应助goth采纳,获得10
1秒前
YJH发布了新的文献求助10
1秒前
2秒前
夏誉玮发布了新的文献求助10
2秒前
2秒前
zhongcaiying完成签到,获得积分20
2秒前
2秒前
yKkkkkk发布了新的文献求助10
3秒前
思源应助ddddd采纳,获得10
4秒前
4秒前
4秒前
Owen应助舒心梦琪采纳,获得10
4秒前
壮观的夏云完成签到,获得积分10
5秒前
淡淡的秋柳完成签到,获得积分10
5秒前
5秒前
5秒前
MM发布了新的文献求助10
5秒前
clamon完成签到,获得积分10
5秒前
婉晴发布了新的文献求助10
6秒前
wjx发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
Erik发布了新的文献求助10
8秒前
8秒前
9秒前
luermei发布了新的文献求助10
9秒前
ww完成签到,获得积分10
9秒前
stefan发布了新的文献求助10
9秒前
zzyytt完成签到,获得积分10
9秒前
10秒前
机灵笑萍发布了新的文献求助10
10秒前
10秒前
11秒前
11秒前
jin晨发布了新的文献求助10
12秒前
及川星月完成签到,获得积分10
12秒前
苏灿应助mrx采纳,获得20
13秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974844
求助须知:如何正确求助?哪些是违规求助? 3519270
关于积分的说明 11197844
捐赠科研通 3255496
什么是DOI,文献DOI怎么找? 1797791
邀请新用户注册赠送积分活动 877187
科研通“疑难数据库(出版商)”最低求助积分说明 806202